**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
For National Family Caregivers Month, Robin Ferrill shares tips from her experience embracing the role after her husband’s GBM diagnosis in 2022.
From groundbreaking research to new collaborations at a federal level, discover the top three brain tumor news highlights and milestones for the year.
After losing her husband to GBM in 2022 and receiving her own diagnosis, survivor Beth Kassab didn’t know what to expect attending the largest brain tumor conference in Chicago. Read Beth’s top takeaways:
After losing her daughter Kristi to GBM in 2011, Sally set out to carry on her daughter’s legacy of living life to the fullest and supporting brain tumor research.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
Join us July 19 to raise $50K for GBM research.
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
David Hou is awarded for his research on leveraging a B cell vaccine to improve immunotherapy treatment for GBM.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
